ArticleVeterinary sciences2026
Capsaicin Improves Lipid Metabolism Disorders Caused by LPS-Induced Immune Stress in Weaned Piglets.
Article in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The purpose of this study was to investigate the effect of capsaicin (CAP) on lipid metabolism in weaned piglets and its related mechanisms. Twenty-four weaned piglets with an initial body weight of 9.00 ± 0.30 kg were randomly divided into three groups, with eight replicates in each group. The control (CON) and lipopolysaccharide (LPS) groups were fed a basal diet, while the LPS and capsaicin group (LCA) received the basal diet supplemented with 4 mg/kg pure capsaicin (delivered via 800 mg/kg additive) for 35 days. About 4 h before sampling, piglets in the LPS and LCA groups were intraperitoneally injected with LPS at a dose of 100 μg/kg body weight, while those in the CON group were intraperitoneally injected with the same dose of normal saline. In this study, we found that the addition of 800 mg/kg CAP to the diet of piglets significantly reduced the accumulation of serum triglyceride (TG), non-esterified fatty acids (NEFA), and liver fat, and that CAP up-regulates expression of genes and proteins in the PPARα pathway, consistent with enhanced fatty acid oxidation. The intervention with 4 mg/kg CAP was also found to down-regulate cholesterol synthesis precursors (such as mevalonate, MVA), reduce pro-inflammatory phospholipids (such as phosphatidic acid-phosphatidylcholine, PA-PC), and modulate bile acid metabolism, thereby beneficially regulating blood lipid profiles (TC, TG, LDL-C) and disrupting the "lipid metabolism-inflammation" interaction cycle. Furthermore, CAP promoted fatty acid β-oxidation and bile acid metabolism by activating the TRPV1 channel, which alleviated hepatic lipid accumulation. These findings indicated that CAP has potential application value in improving lipid metabolism, intestinal health, and immune function in weaned piglets. However, its long-term safety and dose-dependent effects require further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.